AG
ABG-WTT Global Life Science Capital Partners GP Ltd
Concentrated strategyQuality / disciplined sizing
Total reported value
$12.3M
Reporting period: 2026-03-31 · Number of holdings: 2
ABG-WTT Global Life Science Capital Partners GP Ltd disclosed 2 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $12.3M and a quarterly turnover rate of 20.1%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 20.15
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 4
- Sizing Uniformity
- 95.51
Recent moves
Add CBLL
0.0% -$1.6M
Trim RPID
0.0% -$1.2M
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CBLL | Ceribell INC | Stock-Other | 65.87% | +1.49% | — | |
| 2 | RPID | Rapid Micro Biosystems Inc-a | Stock-Other | 34.13% | -1.49% | — |
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 2 | $12.3M | 20 | |
| 2025-12-31 | 2 | $15.0M | 22 | |
| 2025-09-30 | 2 | $18.7M | 98 | |
| 2025-06-30 | 2 | $26.8M | 0 | |
| 2025-03-31 | 4 | $38.3M | 100 | |
| 2024-12-31 | 4 | $43.7M | 0 | |
| 2024-09-30 | 3 | $20.1M | 0 | |
| 2024-06-30 | 3 | $30.0M | 0 | |
| 2024-03-31 | 3 | $41.5M | 0 | |
| 2023-12-31 | 4 | $51.3M | 0 | |
| 2023-09-30 | 4 | $20.8M | 0 | |
| 2023-06-30 | 3 | $5.5M | 0 | |
| 2023-03-31 | 3 | $6.3M | 0 | |
| 2022-12-31 | 3 | $6.2M | 0 | |
| 2022-09-30 | 3 | $16.0M | 0 | |
| 2022-06-30 | 3 | $28.3M | 0 | |
| 2022-03-31 | 3 | $12.3M | 0 | |
| 2021-12-31 | 2 | $7.4M | 0 | |
| 2021-09-30 | 2 | $14.7M | 0 | |
| 2021-06-30 | 2 | $51.7M | 100 | |
| 2021-03-31 | 2 | $91.7M | 22 | |
| 2020-12-31 | 2 | $114.7M | 0 |
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CBLL | Ceribell INC | +1.5% | — | Unchanged |
| 2 | RPID | Rapid Micro Biosystems Inc-a | -1.5% | — | Unchanged |
FAQ
What is ABG-WTT Global Life Science Capital Partners GP Ltd and what type of investor is it?
ABG-WTT Global Life Science Capital Partners GP Ltd is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $12.3M, spread across 2 disclosed positions.
What are ABG-WTT Global Life Science Capital Partners GP Ltd's largest equity positions?
Based on the latest 13F filing, ABG-WTT Global Life Science Capital Partners GP Ltd's top holdings by market value are:
1. Ceribell INC (CBLL) — $8.1M (65.9%)
2. Rapid Micro Biosystems Inc-a (RPID) — $4.2M (34.1%)
What changes did ABG-WTT Global Life Science Capital Partners GP Ltd make in its most recent portfolio filing?
No notable portfolio changes were recorded for ABG-WTT Global Life Science Capital Partners GP Ltd in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does ABG-WTT Global Life Science Capital Partners GP Ltd focus on?
Sector breakdown data is not yet available for ABG-WTT Global Life Science Capital Partners GP Ltd. Check back after the next 13F processing cycle.